Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY10 | O00398 | 8/20 | 0.42 |
| ▸ | GPR34 | Q9UPC5 | 4/20 | 0.42 |
| ▸ | GPR174 | Q9BXC1 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1864332 | 1.00 | P2RY10 (0.42) | P2RY10GPR34GPR174 | |
| SCHEMBL2329616 | 1.00 | P2RY10 (0.42) | P2RY10GPR34GPR174 | |
| SCHEMBL8504216 | 0.89 | P2RY10 (0.45) | P2RY10GPR34GPR174 | |
| SCHEMBL6372215 | 0.83 | PLA2G2C (0.46) | P2RY10GPR34GPR174 | |
| SCHEMBL15022342 | 0.83 | PLA2G2C (0.46) | P2RY10GPR34GPR174 | |
| SCHEMBL1899888 | 0.81 | PRKCA (0.45) | P2RY10GPR34 | |
| SCHEMBL1900343 | 0.81 | PRKCA (0.45) | P2RY10GPR34 | |
| SCHEMBL1556453 | 0.81 | PRKCA (0.45) | P2RY10GPR34 | |
| SCHEMBL8628861 | 0.80 | P2RY10 (0.43) | P2RY10GPR34 | |
| SCHEMBL16964730 | 0.79 | P2RY10 (0.43) | P2RY10GPR34 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2350296-A1 | BRANCHED CATIONIC LIPIDS FOR NUCLEIC ACIDS DELIVERY SYSTEM | Enzon Pharmaceuticals, Inc. (US) | 2011-08-03 | — | — | EP | disclosed |
| WO-2010057160-A9 | RELEASABLE FUSOGENIC LIPIDS FOR NUCLEIC ACIDS DELIVERY SYSTEMS | ENZON PHARMACEUTICALS, INC. (US) | 2011-05-05 | — | — | WO | disclosed |
| WO-2010056403-A1 | BRANCHED CATIONIC LIPIDS FOR NUCLEIC ACIDS DELIVERY SYSTEM | ENZON PHARMACEUTICALS, INC. (US) | 2010-05-20 | — | — | WO | disclosed |